Clinical Fellow in Haematology Early Phase Clinical Trials
| Dyddiad hysbysebu: | 20 Chwefror 2026 |
|---|---|
| Cyflog: | Heb ei nodi |
| Gwybodaeth ychwanegol am y cyflog: | £73,992 per annum plus London weighting |
| Oriau: | Llawn Amser |
| Dyddiad cau: | 22 Mawrth 2026 |
| Lleoliad: | London, NW1 2BU |
| Cwmni: | University College London Hospital |
| Math o swydd: | Cytundeb |
| Cyfeirnod swydd: | 7817585/309-UCLH-7486 |
Crynodeb
A Vacancy at University College London Hospitals NHS Foundation Trust.
Clinical Fellow (ST6) in
Haematology Early Phase Clinical Trials
NIHR UCLH Clinical Research Facility
Applications are invited for Clinical Fellows (ST6) in Haematology Early Phase Clinical Trials from August 2026. The aim of this position is tooffer comprehensive specialist training in all aspects of running early phase haematology clinical trials including protocol development, regulatory procedures, associated translational research projects and presentation of research at meetings.
Cancer is a major strategic area of UCLH and UCL with a focus on developing novel pathway-directed therapies. There is an excellent infrastructure allowing clinical trials to be linked with basic science, facilitating targeting of specific molecular abnormalities in cancers with therapeutics. UCL is both an Experimental Cancer Medicine Centre and a Cancer Research UK Centre, and the NIHR UCLH Clinical Research Facility (http://www.uclhospitals.brc.nihr.ac.uk/crf/national-institute-health-researchwellcome-uclh-clinical-research-facility) is supported by the NIHR and Cancer Research UK. There are close links between the CRF and the UCL Cancer Institute (http://www.ucl.ac.uk/cancer/) providing excellent opportunities for translational research projects linked to drug development.
The aim of this position is to offer comprehensive specialist training in all aspects of early phase Haem-Oncology clinical trials including protocol development, regulatory procedures, associated translational research projects and presentation of research at meetings.
This full-time, fixed-term post will be for a period of 12 months from August 2026. Full GMC Registration is essential and possession of MRCP or equivalent is necessary. Specialist training in haematology or oncology and competency in prescribing chemotherapy is required, experience in clinical trial work is desirable
University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research.
We provide first-class acute and specialist services across eight sites:
• University College Hospital (incorporating the Elizabeth Garrett Anderson Wing)
• National Hospital for Neurology and Neurosurgery
• Royal National ENT and Eastman Dental Hospitals
• University College Hospital Grafton Way Building
• Royal London Hospital for Integrated Medicine
• University College Hospital Macmillan Cancer Centre
• The Hospital for Tropical Diseases
• University College Hospital at Westmoreland Street
We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women’s health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.
We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.
For the full Person Specification and more information regarding the main responsibilities of this role, please refer to the attached Job Description.
Please note, due to anticipated high volumes of applications, this vacancy may close earlier than the listed closing date. You are advised not to delay submitting your completed application
Come and be a part of the best NHS trust in England to work for, according to our staff*
* UCLH top trust to work at in England - In the most recent NHS staff survey UCLH had the highest percentage of staff who said they would recommend us as a place to work, out of all general acute or acute/community NHS trusts in England – for the third year in a row.
UCLH recognises the benefits of flexible working for staff – To find out more, visit: Flexible working.
To discover more about what makes UCLH a great place to work, visit: Why Choose UCLH?
This advert closes on Sunday 8 Mar 2026
Clinical Fellow (ST6) in
Haematology Early Phase Clinical Trials
NIHR UCLH Clinical Research Facility
Applications are invited for Clinical Fellows (ST6) in Haematology Early Phase Clinical Trials from August 2026. The aim of this position is tooffer comprehensive specialist training in all aspects of running early phase haematology clinical trials including protocol development, regulatory procedures, associated translational research projects and presentation of research at meetings.
Cancer is a major strategic area of UCLH and UCL with a focus on developing novel pathway-directed therapies. There is an excellent infrastructure allowing clinical trials to be linked with basic science, facilitating targeting of specific molecular abnormalities in cancers with therapeutics. UCL is both an Experimental Cancer Medicine Centre and a Cancer Research UK Centre, and the NIHR UCLH Clinical Research Facility (http://www.uclhospitals.brc.nihr.ac.uk/crf/national-institute-health-researchwellcome-uclh-clinical-research-facility) is supported by the NIHR and Cancer Research UK. There are close links between the CRF and the UCL Cancer Institute (http://www.ucl.ac.uk/cancer/) providing excellent opportunities for translational research projects linked to drug development.
The aim of this position is to offer comprehensive specialist training in all aspects of early phase Haem-Oncology clinical trials including protocol development, regulatory procedures, associated translational research projects and presentation of research at meetings.
This full-time, fixed-term post will be for a period of 12 months from August 2026. Full GMC Registration is essential and possession of MRCP or equivalent is necessary. Specialist training in haematology or oncology and competency in prescribing chemotherapy is required, experience in clinical trial work is desirable
University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research.
We provide first-class acute and specialist services across eight sites:
• University College Hospital (incorporating the Elizabeth Garrett Anderson Wing)
• National Hospital for Neurology and Neurosurgery
• Royal National ENT and Eastman Dental Hospitals
• University College Hospital Grafton Way Building
• Royal London Hospital for Integrated Medicine
• University College Hospital Macmillan Cancer Centre
• The Hospital for Tropical Diseases
• University College Hospital at Westmoreland Street
We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women’s health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.
We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.
For the full Person Specification and more information regarding the main responsibilities of this role, please refer to the attached Job Description.
Please note, due to anticipated high volumes of applications, this vacancy may close earlier than the listed closing date. You are advised not to delay submitting your completed application
Come and be a part of the best NHS trust in England to work for, according to our staff*
* UCLH top trust to work at in England - In the most recent NHS staff survey UCLH had the highest percentage of staff who said they would recommend us as a place to work, out of all general acute or acute/community NHS trusts in England – for the third year in a row.
UCLH recognises the benefits of flexible working for staff – To find out more, visit: Flexible working.
To discover more about what makes UCLH a great place to work, visit: Why Choose UCLH?
This advert closes on Sunday 8 Mar 2026
Aelod balch o'r cynllun cyflogwyr Hyderus o ran Anabledd
Hyderus o ran Anabledd
Gwybodaeth am Hyderus o ran Anabledd
Yn gyffredinol, bydd cyflogwr Hyderus o ran Anabledd yn cynnig cyfweliad i unrhyw ymgeisydd sy'n datgan eu bod yn anabl ac yn bodloni'r meini prawf lleiaf ar gyfer y swydd fel y diffinnir gan y cyflogwr. Mae'n bwysig nodi, mewn rhai sefyllfaoedd recriwtio fel nifer fawr o ymgeiswyr, cyfnod tymhorol ac amseroedd prysur iawn, efallai y bydd y cyflogwr am gyfyngu ar y niferoedd cyffredinol o gyfweliadau a gynigir i bobl anabl a phobl nad ydynt yn anabl. Am fwy o fanylion ewch i Hyderus o ran Anabledd.